PTGX
#1009
Protagonist Therapeutics, Inc. - Common Stock
137.3 9 USD
+0.05%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+4.66%
Changement Mensuel
+21.77%
Evolution sur 6 mois
+62.57%
Changement Annuel
+82.87%
Clôture Précédente
131.2 7
Open
136.4 8
Low
136.1 9
High
138.6 0
Volume
253
Financials
- Market Capitalization 8.84 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-58.23
ratio cours/chiffre d'affaires
97.79
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.91 USD | +0.24% | +0.49% | +137.98% | +104.16% | 8.85 B USD | ||
| 1005 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 101.65 USD | +2.73% | +9.58% | +21.68% | +325.14% | 8.83 B USD | ||
| 1021 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.26 USD | +0.22% | +0.58% | +55.77% | +150.53% | 8.31 B USD | ||
| 1023 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.85 USD | +1.75% | -1.33% | +11.39% | +45.86% | 8.55 B USD |